Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 clinical trial investigating autologous bronchial basal cell transplantation for bronchiectasis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous bronchial basal cell transplantation

Snippet

Sponsor: Regend Therapeutics | Conditions: Bronchiectasis | Phase 1, Phase 2 | Status: UNKNOWN